Lv63
2456 积分 2024-10-28 加入
M1/M4 receptors as potential therapeutic treatments for schizophrenia: A comprehensive study
9天前
已完结
IUPHAR Review on muscarinic M1 and M4 receptors as drug treatment targets relevant to the molecular pathology of schizophrenia
9天前
已完结
Xanomeline/Trospium (Cobenfy): A Novel Approach for the Treatment of Schizophrenia in Adults
9天前
已关闭
Low incidence of extrapyramidal symptoms following treatment with a muscarinic agonist medication for schizophrenia
9天前
已完结
Targeting muscarinic receptors for treating schizophrenia
9天前
已关闭
Non‐clinical Efficacy and Safety of SUVN‐L3307032, a Muscarinic M4 Positive Allosteric Modulator (M4 PAM), for the Treatment of Neuropsychiatric Symptoms
9天前
已完结
Current Findings and Potential Mechanisms of KarXT (Xanomeline–Trospium) in Schizophrenia Treatment
9天前
已完结
Muscarinic M1 and M4 receptor agonists for schizophrenia: promising candidates for the therapeutic arsenal
9天前
已完结
Design, synthesis, and pharmacological evaluation of novel M4 muscarinic receptor positive allosteric modulators for schizophrenia treatment
9天前
已完结
Psychosis as a disorder of muscarinic signalling: psychopathology and pharmacology
9天前
已完结
皖公网安备34019202002308
